Graham's Exit Leaves Void in Global Health Advocacy

Sen. Lindsey Graham has been a quiet but powerful force in advancing global health funding in Congress, and his departure leaves advocates scrambling to identify a successor. Sen. Chris Van Hollen, a Maryland Democrat, singled out PEPFAR (the President's Emergency Plan for AIDS Relief) as an area where Graham's advocacy made a concrete difference. "Senator Graham understood the critical impact PEPFAR has had in saving lives around the world, and he understood the importance of reauthorizing PEPFAR," Van Hollen said in a statement. What made Graham's role distinctive, according to Elizabeth Hoffman, executive director for North America at the ONE Campaign, was that he exercised outsized influence precisely by avoiding the spotlight. "He was one of the most consequential global health voices on the Republican side, precisely because he wasn't always loud about it," Hoffman said. She added: "The question now is who is prepared to carry that commitment forward." Tom Malinowski, who worked with Graham on human rights funding both during his tenure in the Obama administration and later in Congress, was candid about the challenge ahead. "I worry that there isn't" anyone else positioned to fill that role, Malinowski said. "Lindsey was the guy everybody went to."

Lindsey Graham's departure from Congress marks the loss of a rare bipartisan bridge on global health advocacy. According to advocates quoted in the article, Graham's effectiveness lay not in flashy public campaigns but in behind-the-scenes advocacy that secured funding reauthorizations and cross-party support. His work on PEPFAR, highlighted by Democratic Sen. Van Hollen, demonstrates how a Republican voice committed to international health spending could advance these priorities in a polarized Congress. The anxiety expressed by Tom Malinowski—who worked alongside Graham on human rights funding across two administrations—reflects a structural gap: Graham was not simply a voice for global health, but the person other advocates "went to" when they needed legislative momentum. His exit leaves that role unfilled at a time when international health funding faces political headwinds.